臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 221-270 / 1137 (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-17T03:21:17Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2021-09-17T03:21:16Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-09-17T02:51:01Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2021-09-17T02:50:57Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2021-09-17T02:50:52Z	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort	Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-09-17T02:50:51Z	Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study	MENG-RUI LEE; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-09-15T01:20:52Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2021-09-15T01:20:50Z	MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process	Wang H.-Y.; Liu Y.-N.; Wu S.-G.; CHIA-LANG HSU; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.
臺大學術典藏	2021-09-15T01:20:46Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; CHIA-LANG HSU; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.
臺大學術典藏	2021-09-09T05:25:29Z	Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib	ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏	2021-09-09T05:25:27Z	Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients	ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-09-02T00:08:47Z	Dual energy CT image prediction on primary tumor of lung cancer for nodal metastasis using deep learning	Wang Y.-W;Chen C.-J;Huang H.-C;Wang T.-C;Chen H.-M;Shih J.-Y;Chen J.-S;Huang Y.-S;Chang Y.-C;Chang R.-F.; Wang Y.-W; Chen C.-J; Huang H.-C; Wang T.-C; Chen H.-M; Shih J.-Y; Chen J.-S; Huang Y.-S; Chang Y.-C; Chang R.-F.; RUEY-FENG CHANG
臺大學術典藏	2021-09-01T01:54:28Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏	2021-09-01T01:54:26Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:21Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏	2021-09-01T01:53:45Z	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas	Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:47Z	The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases	Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; Lan K.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T06:29:18Z	Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer	Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; ANN-LII CHENG; Kuo S.-H.
臺大學術典藏	2021-08-31T05:44:41Z	A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor	LUN-CHE CHEN; Shih J.-Y.; Yu C.-J.; Yang C.-Y.
臺大學術典藏	2021-08-31T05:27:02Z	Effects of left atrial strain on functional capacity in chronic severe mitral regurgitation	LI-TAN YANG; Shih J.-Y.; Liu Y.-W.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏	2021-08-31T05:27:00Z	Predictive value of left atrial deformation on prognosis in severe primary mitral regurgitation	LI-TAN YANG; Liu Y.-W.; Shih J.-Y.; Li Y.-H.; Tsai L.-M.; Luo C.-Y.; Tsai W.-C.
臺大學術典藏	2021-08-31T03:33:46Z	Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation	Keng L.-T.; Chung K.-P.; SHU-YUNG LIN; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-31T03:33:46Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	Liao B.-C.; Bai Y.-Y.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J.
臺大學術典藏	2021-08-31T03:33:45Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-08-31T03:33:45Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; SHU-YUNG LIN; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2021-08-31T03:33:44Z	Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma	Lu H.-H.; SHU-YUNG LIN; Weng R.R.; Juan Y.-H.; Chen Y.-W.; Hou H.-H.; Hung Z.-C.; Oswita G.A.; Huang Y.-J.; Guu S.-Y.; Khoo K.-H.; Shih J.-Y.; Yu C.-J.; Tsai H.-C.
臺大學術典藏	2021-08-24T02:10:12Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; TAO-MIN HUANG; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-24T00:33:36Z	The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma	YAO-WEN KUO; Jerng J.-S.; Shih J.-Y.; Chen K.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-24T00:33:36Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	YAO-WEN KUO; Wu S.-G.; Ho C.-C.; Shih J.-Y.
臺大學術典藏	2021-08-24T00:33:35Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; YAO-WEN KUO; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:36Z	Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed	CHUNG-YU CHEN; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:33Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	CHUNG-YU CHEN; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:33Z	Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer	CHUNG-YU CHEN; Lin J.-W.; Huang J.-W.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:32Z	Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit	Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; CHUNG-YU CHEN; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:31Z	Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression	CHUNG-YU CHEN; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏	2021-08-23T03:20:30Z	Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study	Chen Y.-H.; Chen Y.-F.; CHUNG-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:27Z	Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer	CHUNG-YU CHEN; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T02:42:25Z	Miliary pulmonary nodules: An unusual presentation of leptospirosis	YUNG-HSUAN CHEN; Yang C.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-23T02:42:24Z	Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study	YUNG-HSUAN CHEN; Chen Y.-F.; Chen C.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:43Z	Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy	BIN-CHI LIAO; Lin C.C.; Shih J.Y.; Yang J.C.H.
臺大學術典藏	2021-08-20T08:00:42Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis	BIN-CHI LIAO; Lee J.-H.; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏	2021-08-20T08:00:42Z	151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs	BIN-CHI LIAO; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J.
臺大學術典藏	2021-08-20T08:00:40Z	Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors	BIN-CHI LIAO; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏	2021-08-20T08:00:40Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; BIN-CHI LIAO; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:39Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:38Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:38Z	Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC	BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H.
臺大學術典藏	2021-08-16T03:26:38Z	Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation	Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; I-CHUN CHEN; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2021-08-11T03:46:53Z	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy	Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏	2021-08-11T03:46:51Z	EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment	Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Cheng A.-L.; Yang P.-C.

顯示項目 221-270 / 1137 (共23頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52845762 線上人數 : 675 教育部委託研究計畫計畫執行:國立臺灣大學圖書館